Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Journal of Medical Economics Volume 24, 2021 - Issue 1

Submit an article Journal homepage

Open access

4,820

Views

CrossRef citations to date

Altmetric

Neurology

Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia

Michael L. Ganza Real-world Evidence, Evidera, Waltham, MA, USACorrespondence[email protected]

https://orcid.org/0000-0002-9702-2999

Ameya Chavanb Evidence Synthesis, Modeling & Communication, Evidera, Bethesda, MD, USA

Rahul Dhandac Neurocrine Biosciences, Inc, San Diego, CA, USA

https://orcid.org/0000-0002-6941-3853

Michael Serbinc Neurocrine Biosciences, Inc, San Diego, CA, USA

https://orcid.org/0000-0001-6876-7150

Charles Yonanc Neurocrine Biosciences, Inc, San Diego, CA, USA

Pages 103-113 | Received 17 Sep 2020, Accepted 09 Dec 2020, Published online: 20 Jan 2021

Cite this article
https://doi.org/10.1080/13696998.2020.1867443
CrossMark

Full Article
Figures & data
References
Supplemental
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Michael Serbin, Charles Yonan & Michael L. Ganz. (2021) In Reply to Xue W, Ribalov R, Zhou Z-Y, et al. Re: Ganz ML, Chavan A, Dhanda R, et al. Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia. J Med Econ. 2021;24(1):103–113. Journal of Medical Economics 24:1, pages 891-892.
Read now

Weiguang Xue, Rinat Ribalov, Zheng-Yi Zhou, Rajeev Ayyagari & Sam Leo. (2021) Re: Ganz ML, Chavan A, Dhanda R, et al. Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia. J Med Econ. 2021;24(1):103–113. Journal of Medical Economics 24:1, pages 835-836.
Read now

Articles from other publishers (1)

Brandon Chua, Li Min Lim, Joseph Soon Yau Ng, Yan Ma, Hwee Lin Wee & J. Jaime Caro. (2023) Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore. Cancers 15:6, pages 1812.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references